Made Tech shares could be a promising long term buy for position investors with a basic understanding of the numbers. Made Tech (LON: MTEC) has not exactly put forth a stellar performance since launching its IPO in September 2021, falling from 122p at launch to just 27p today. To be fair to the FTSE AIM […]

Polarean Imaging shares constitute another FTSE AIM favourite waiting for a buyout after FDA approval of its novel MRI tech. Polarean Imaging (LON: POLX) shares have been on my radar for some time, but the FTSE AIM company has now fallen by 18.5% to 53p over the past five days, providing what could be a […]

TGR shares could now be trading at a discount to their fair value given the company’s high-quality graphite reserves and strong half-year results. Tirupati Graphite (LON: TGR) investors haven’t been a particularly pleasant experience over the past year. The London-listed company’s shares have fallen by 75% from 140p in July 2021 to just 35p today […]

RENE shares have gone from being a FTSE AIM favourite to collapsing by 95% over the past five years. But a moderate recovery is not impossible in 2023. ReNeuron (LON: RENE) shares were at one point one of the hottest UK biotech stocks, soaring to over 300p at several points during mid-2019. But the FTSE […]

Corcel shares are underloved, undervalued, and underappreciated. A perfect combination for high-risk FTSE AIM investors. As a long-term investor, I rarely trade on leverage in FTSE AIM stocks, preferring instead the old-fashioned method of buying shares and waiting a decent length of time before taking profits. In particular, I enjoy looking for unloved, oversold companies […]

Full planning permission for Alkemy’s lithium processing plant could just be the start of the share price rocket. Alkemy Capital (LON: ALK) hit the headlines late last month after announcing that it has been given permission to build Europe’s largest lithium refinery in Teesside, UK. With its shares now having rocketed by 189% year-to-date to […]

Polymetal shares could soar if dividends restart, if it splits its assets, or if peace in Ukraine becomes a political reality. Polymetal (LON: POLY) is arguably the company which would most benefit from a peace deal brokered between Russia and Ukraine. The London-Moscow dual-listed gold miner, which was struck off the FTSE 100 earlier this […]

GCAT shares have fallen hard over the past year. But its $10.5 million agreement with OCIM has put it on my radar for 2023. As an afficionado of downtrodden penny gold stocks, Caracal Gold (LON: GCAT) shares leap out as a long-term portfolio opportunity for 2023. The exploratory gold miner struck a record 1.70p per […]

Lithium, Nickel, and Copper are well-known as the shortage materials for the EV revolution. But their neglected younger brother should also feature in a well-diversified portfolio. A key tenet of my investing philosophy is diversification of risk. This means that while exploratory lithium, copper and gold miners remain my favourite types of stocks, a good […]

Premier African Minerals, Harland &Wolff, Baron Oil, and Avacta could constitute 4 high-risk plays for investors with nerves of steel. The best FTSE AIM shares are often quoted as those experiencing predictable growth that will allow them to eventually see promotion into the premium FTSE 250 segment of the London Stock Exchange.   However, with […]

Avacta is spending big on both acquisitions and R&D. But its near-term trajectory depends on the success of its proposed cancer wonder drug. Avacta (LON: AVCT) shares have enjoyed the rollercoaster ride typical of many minor biomedical companies. The FTSE AIM firm was swept up in the speculative frenzy of the pandemic-era lockdowns, soaring to […]

Meta shares are rising as CEO Mark Zuckerberg pivots investment away from the Metaverse. A TikTok ban could catalyse the rocket. Three things are holding back Meta Platforms’ (NASDAQ: META) share price. The first was changes to Apple’s privacy terms, which is costing the social media platform circa $10 billion per year. The second is […]